Drug Topics
JULY 4, 2024
“Adding this technology to our pandemic flu toolkit enhances our ability to be nimble and quick against the circulating strains and their potential variants,” said Dawn O’Connell, assistant secretary for preparedness and response at the HSS.
pharmaphorum
JULY 4, 2024
Changing Faces explores the digital and supplier hires from April 2024, with a focus on companies like SPT Labtech, Sphere Fluidics, Newel Health, and Diaceutics. Stay updated on the latest developments in the industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JULY 4, 2024
Altering the conditions that T cells are grown in can improve CAR T-cell therapy, US researchers have found. Discovered by chance, their new method has potential to treat solid cancer tumours more efficiently, according to the findings. Putting T cells on a keto diet [putting our T cells on a three-day ‘keto’ diet] showed reduced maturity at the end of the manufacturing process.
pharmaphorum
JULY 4, 2024
Pieris' immuno-oncology alliance with Servier is being dissolved after a trial of the lead drug in the alliance revealed a safety concern.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
JULY 4, 2024
This narrative review dispels the long-held belief that reduction in salt intake leads to better health outcomes in patients with heart failure.
pharmaphorum
JULY 4, 2024
UK survey finds more than two-thirds of people with chronic hand eczema say it has affected their relationships and/or working life.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
JULY 4, 2024
The US government has signed a $176 million deal with Moderna to develop an mRNA-based pandemic influenza vaccine.
Outsourcing Pharma
JULY 4, 2024
Preclinical results show promise for Tyra Bioscienceâs lead drug candidate for the treatment for hypochondroplasia, a condition for which there are currently no therapeutic options available.
pharmaphorum
JULY 4, 2024
AI developed by Pangea Biomed predicts the chances that a patient will respond to cancer treatment by looking at tumour images.
Pharmacy Times
JULY 4, 2024
Investigators found improvements over the placebo in metabolic dysfunction-associated steatohepatitis without worsening fibrosis across 3 dosing groups.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
JULY 4, 2024
A Connecticut federal judge has rejected Boehringer Ingelheim's challenge to Medicare’s drug price negotiation programme.
Outsourcing Pharma
JULY 4, 2024
Under the terms of the agreement, Eli Lilly will obtain the exclusive rights to acquire Radionetics Oncology for $1 billion.
OctariusRx
JULY 4, 2024
Let Freedom Ring! From all of us at OctariusRx, Happy Independence Day ! Thank you to all who serve or have served our Nation in pursuit of the freedom we enjoy today and every day! “We identify the flag with almost everything we hold dear on earth: peace, security, liberty, our family, our friends, our home … But when we look at our flag and behold it, emblazoned with all our rights, we must remember that it is equally a symbol of our duties.
Outsourcing Pharma
JULY 4, 2024
CatSci, a UK-based innovation partner for the development of pharmaceutical manufacturing processes, will be expanding its service offering with the acquisition of Reach Separations.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
JULY 4, 2024
The UK’s Medicine and Healthcare Products Regulatory Agency (MHRA) introduced changes to streamline its drug approval processes.
Outsourcing Pharma
JULY 4, 2024
Preclinical results show promise for Tyra Bioscienceâs lead drug candidate for the treatment for hypochondroplasia, a condition for which there are currently no therapeutic options available.
Pharma Times
JULY 4, 2024
Aggressive prostate cancer accounts for up to 15% of all prostate cancer diagnoses
BioPharm
JULY 4, 2024
The companies have restructured their existing collaboration into a licensing agreement that invests in mRNA development.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
JULY 4, 2024
In the UK, the progressive neurodegenerative condition affects around 153,000 people
Hospital Pharmacy Europe
JULY 4, 2024
The results of a national audit and quality improvement project looking to optimise cardiovascular treatment and care across Italy has recently been presented at the Italian National Association of Hospital Cardiologists conference. Here, Professor Furio Colivicchi speaks to Helen Quinn about the rationale for the audit study, the key findings and next steps, plus the team’s ambitions to widen the scope of the project to support more patients nationally and across Europe.
Pharmaceutical Commerce
JULY 4, 2024
The latest news for pharma industry insiders.
PharmExec
JULY 4, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Commerce
JULY 4, 2024
The investment is expected to help enhance the company temperature-controlled services in the Netherlands, France Italy, and Hungary.
PharmExec
JULY 4, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmacy Times
JULY 4, 2024
Antibody-drug conjugates (ADCs) revolutionize cancer therapy by delivering powerful drugs directly to tumors and minimize damage to healthy cells.
The Happy PharmD
JULY 4, 2024
Are you considering a career in compounding pharmacy? Let me take you on a journey into the world of compounding pharmacists, where we dive into everything from job satisfaction to salary expectations. [link] Compounding pharmacists are the alchemists of the pharmacy world, crafting customized medications tailored to individual patient needs. Unlike typical pharmacists who dispense pre-made medications, compounding pharmacists mix raw materials to create specific formulations, whether it’s
European Pharmaceutical Review
JULY 4, 2024
In the US, botanical dietary supplements can be sold without US Food and Drug Administration (FDA) approval, 1 prompting many vendors to promote the use of botanical products as dietary supplements , 2 rather than pursue a path of regulatory approval. However, as with drugs, dietary supplements require evidence that they are safe and that claims on product labels are truthful and not misleading. 1 For use as prescription drugs, a botanical product must be approved by the FDA: to date, only two h
Expert insights. Personalized for you.
502 
Let's personalize your content